Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
about
Harnessing the Power of Defensive Microbes: Evolutionary Implications in Nature and Disease ControlInsights into Newer Antimicrobial Agents Against Gram-negative BacteriaThree New Escherichia coli Phages from the Human Gut Show Promising Potential for Phage TherapyThe Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-LactamsIsolation and Host Range of Bacteriophage with Lytic Activity against Methicillin-Resistant Staphylococcus aureus and Potential Use as a Fomite DecontaminantOn the origin of species: Factors shaping the establishment of infant's gut microbiota.Klebsiella pneumoniae subsp. pneumoniae-bacteriophage combination from the caecal effluent of a healthy woman.The Janus-Face of Bacteriophages across Human Body Habitats.Bioinformatics as a first-line approach for understanding bacteriophage transcriptionCharacterization of Pseudomonas aeruginosa Phage C11 and Identification of Host Genes Required for Virion MaturationCurrent concepts in the pathogenesis and treatment of chronic suppurative otitis media.Development of a Phage Cocktail to Control Proteus mirabilis Catheter-associated Urinary Tract Infections.Bacteriophage tailspike protein based assay to monitor phase variable glucosylations in Salmonella O-antigens.Modification of Escherichia coli-bacteriophage interactions by surfactants and antibiotics in vitro.Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.Genetically modified bacteriophages.Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia.Bacteriophages and its applications: an overview.Control of Multidrug-Resistant Gene Flow in the Environment Through Bacteriophage Intervention.Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages.Management of urinary tract infections in patients with neurogenic bladder: challenges and solutions.Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.Long-term effects of single and combined introductions of antibiotics and bacteriophages on populations of Pseudomonas aeruginosa.First complete genome sequence of a virulent bacteriophage infecting the opportunistic pathogen Serratia rubidaea.Preliminary survey of local bacteriophages with lytic activity against multi-drug resistant bacteria.Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition.Viral communities of the human gut: metagenomic analysis of composition and dynamics.Antimicrobial agents - optimising the ecological balance.Recombinant Endolysins as Potential Therapeutics against Antibiotic-Resistant Staphylococcus aureus: Current Status of Research and Novel Delivery Strategies.Antagonistic Microbial Interactions: Contributions and Potential Applications for Controlling Pathogens in the Aquatic Systems.Csl2, a novel chimeric bacteriophage lysin to fight infections caused by Streptococcus suis, an emerging zoonotic pathogen.Differential Effect of Newly Isolated Phages Belonging to PB1-Like, phiKZ-Like and LUZ24-Like Viruses against Multi-Drug Resistant Pseudomonas aeruginosa under Varying Growth Conditions.Isolation of Potential Phages against Multidrug-Resistant Bacterial Isolates: Promising Agents in the Rivers of Kathmandu, Nepal.Structural investigation by tandem mass spectrometry analysis of a heterogeneous mixture of Lipid An isolated from the lipopolysaccharide of Aeromonas hydrophila SJ-55Ra.Bacteriophage effectively kills multidrug resistant Staphylococcus aureus clinical isolates from chronic rhinosinusitis patients.Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.1st German Phage Symposium-Conference Report.In Vitro Characteristics of Phages to Guide 'Real Life' Phage Therapy Suitability.Adaptation of Pseudomonas aeruginosa to Phage PaP1 Predation via O-Antigen Polymerase Mutation.
P2860
Q26750596-B29B8A60-A988-4D18-B969-52C6C7711304Q26751255-7AFF09FD-DE6A-42BC-BB43-AC332AE3DD9DQ28550170-E69E4688-B26E-4FF7-A613-079C1716DA51Q33696025-A1665A53-5AEB-4E3C-A803-7225650C0C02Q35679714-8517C7F1-C2FC-496D-82A1-A1CC7A9B7DCEQ35853017-0197D825-4520-45B8-A348-14B605D7C787Q35918527-2C524C4A-55E4-45D2-9F1F-70ABF7A2C48DQ36060279-BACF5901-AA86-492E-882B-5FD9BF4A2989Q36105783-0DA74683-10C6-4497-A574-AF22E9C2F52CQ36230120-EB603BE4-4968-4BA4-A44F-599785202B81Q36810844-3B441178-8AB1-411F-93FB-1C894BC60A89Q37043292-E3D43FFA-43C7-426E-BE57-D1B7E8E72DD5Q37240274-08E028B0-9983-4E4B-B4E5-654EEB0EEFF2Q37387916-9418ADE3-F2BA-482C-9021-18C5FAE5BA61Q38247296-AA186F29-4F7D-4F36-A478-435F46A1DE55Q38746993-EE8BD29F-E710-493A-831F-091BBFFB7BE2Q38902086-BAB54217-C6FA-4BAC-A267-8B73F13C947AQ38975521-43BD3B7D-DCFD-47EC-8035-EAF55812E7F6Q38976992-07D2B8B9-0E80-4216-BA10-345650594A59Q39023156-AC3108C1-72AC-4C0B-AB80-880FABF917F3Q39083103-75ABB160-040C-4514-B330-64D1CB6E41F1Q40111907-9BC5F031-3EDF-4F15-B3DD-B0ADB27B9457Q40155162-AB5C0DB8-0A4B-4773-9D30-0DE1C3A02C02Q40165457-F7A67B1C-4F13-43F4-8F69-E72457B42306Q40305582-A1E56507-A0AA-468D-A2A6-818AC904A796Q40668645-726BECD4-062D-436C-9A50-1B19F210EE2AQ40757720-0F3A6E77-B2C0-4964-BD96-6F16620BF2FDQ42281233-BD049BFD-BA7E-4816-B8E5-EA7929C8291AQ42376673-87FEB00C-7CA8-407A-83E5-E3063DCC9F2BQ46251747-2D3C2EB4-1962-4E99-B60B-60A4E236530BQ47118120-C79A9468-29D0-4FD4-BE42-0D49A1F20F8CQ47127198-1A38D586-22AD-4D64-822C-0AF611564DF6Q47150323-60D6F096-7F74-4E72-B6BE-39ADDAC95D1DQ47705521-4D0C896E-79C6-4A9D-8E1A-4DCF798DDCB8Q48050832-7F01A75F-8894-4928-B3B2-D14C1BB1EFBEQ50145275-EB9FCA0B-1B82-447C-B158-3C171ACCCEB0Q52315864-4DFB1A72-FD54-4251-AA32-13EC2593B718Q52622270-79D08E3F-9DA8-4093-9EC4-FE5D592975DAQ53699945-F5B7DE0F-DD00-4054-8222-927AB55E1532Q55234459-54D83286-F2C2-4799-8312-E7B596F21F41
P2860
Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Viruses versus bacteria-novel ...... multidrug-resistant pathogens.
@en
type
label
Viruses versus bacteria-novel ...... multidrug-resistant pathogens.
@en
prefLabel
Viruses versus bacteria-novel ...... multidrug-resistant pathogens.
@en
P2860
P356
P1476
Viruses versus bacteria-novel ...... multidrug-resistant pathogens
@en
P2093
Klaus Ritter
Tania Mareike Viertel
P2860
P304
P356
10.1093/JAC/DKU173
P407
P577
2014-05-28T00:00:00Z